Free Trial

Aura Biosciences (AURA) SEC Filings & 10K Form

Aura Biosciences logo
$7.51 -0.12 (-1.57%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$7.71 +0.20 (+2.66%)
As of 02/21/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aura Biosciences SEC Filings

DateFilerForm TypeView
02/18/2025
6:30 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:30 PM
Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:31 PM
Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:31 PM
Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:31 PM
Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
6:32 PM
Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
6:32 PM
Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
6:32 PM
Aura Biosciences (Subject)
Plavsic Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
10:56 AM
Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
4:51 PM
Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM
Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM
Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:52 PM
Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:52 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
8:09 PM
Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
8:09 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
8:10 PM
Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
8:10 PM
Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
6:20 PM
Aura Biosciences (Subject)
Long Focus Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
11/18/2024
8:06 PM
Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:32 PM
Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:50 PM
Aura Biosciences (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G/A
11/12/2024
8:32 AM
Adage Capital Management, L.P. (Filed by)
Aura Biosciences (Subject)
Form SC 13G/A
10/29/2024
7:33 PM
Aura Biosciences (Subject)
Feder Julie B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
7:33 PM
Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
7:38 PM
Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
7:23 PM
Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
7:28 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
7:18 PM
Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
5:06 PM
Aura Biosciences (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/21/2024
5:23 PM
Aura Biosciences (Issuer)
Feder Julie B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
7:08 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:21 PM
Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:21 PM
Aura Biosciences (Subject)
Feder Julie B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
4:10 PM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
8:22 PM
Aura Biosciences (Subject)
Plavsic Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
8:25 PM
Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:08 PM
Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:05 PM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:50 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Has Trump finally met his match? (Ad)

Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?

Click here for his emergency broadcast...
08/08/2024
6:10 AM
Aura Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/14/2024
3:37 PM
Aura Biosciences (Filer)
Form 10-K/A
06/14/2024
3:42 PM
Aura Biosciences (Filer)
Form DEFA14A
05/09/2024
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:10 AM
Aura Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/07/2024
11:15 PM
Aura Biosciences (Filer)
Form EFFECT
04/04/2024
3:10 PM
Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:59 AM
Aura Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2024
7:12 AM
Aura Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2024
6:11 AM
Aura Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
6:05 AM
Aura Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:22 PM
Aura Biosciences (Subject)
Rich Cadmus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AURA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners